High-Density Lipoprotein Function in Exudative Age-Related Macular Degeneration

被引:8
|
作者
Pertl, Laura [1 ]
Kern, Sabine [2 ]
Weger, Martin [1 ]
Hausberger, Silke [1 ]
Trieb, Markus [2 ]
Gasser-Steiner, Vanessa [1 ]
Haas, Anton [1 ]
Scharnagl, Hubert [3 ]
Heinemann, Akos [2 ]
Marsche, Gunther [2 ]
机构
[1] Med Univ Graz, Dept Ophthalmol, Graz, Austria
[2] Med Univ Graz, Inst Expt & Clin Pharmacol, Graz, Austria
[3] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria
来源
PLOS ONE | 2016年 / 11卷 / 05期
基金
奥地利科学基金会;
关键词
CHOLESTEROL EFFLUX CAPACITY; RISK-FACTORS; CARDIOVASCULAR-DISEASE; GENETIC-VARIANTS; HDL; ATHEROSCLEROSIS; ASSOCIATION; PREVALENCE; METABOLISM; BIOLOGY;
D O I
10.1371/journal.pone.0154397
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Purpose High-density lipoproteins (HDL) have long been implicated in the pathogenesis of age-related macular degeneration (AMD). However, conflicting results have been reported with regard to the associations of AMD with HDL-cholesterol levels. The present study is the first to assess HDL composition and metrics of HDL function in patients with exudative AMD and control patients. Methods Blood samples were collected from 29 patients with exudative AMD and 26 age-matched control patients. Major HDL associated apolipoproteins were determined in apoB-depleted serum by immunoturbidimetry or ELISA, HDL-associated lipids were quantified enzymatically. To get an integrated measure of HDL quantity and quality, we assessed several metrics of HDL function, including cholesterol efflux capacity, anti-oxidative and anti-inflammatory activities using apoB-depleted serum from study participants. Results In our study, we observed that the HDL associated acute phase protein serum amyloid A (SAA) was significantly increased in AMD patients (p<0.01), whereas all other assessed apolipoproteins including ApoA-I, apoA-II, apoC-II, apoC-III and apoE as well as major HDL associated lipids were not altered. HDL efflux capacity, anti-oxidative capacity and arylesterase activity were not different in AMD patients when compared with the control group. The ability of apoB-depleted serum to inhibit monocyte NF-kappa B expression was significantly improved in AMD patients (mean difference (MD) -5.6, p<0.01). Moreover, lipoprotein-associated phospholipase A2 activity, a marker of vascular inflammation, was decreased in AMD subjects (MD -24.1, p<0.01). Conclusions The investigated metrics of HDL composition and HDL function were not associated with exudative AMD in this study, despite an increased content of HDL associated SAA in AMD patients. Unexpectedly, anti-inflammatory activity of apoB-depleted serum was even increased in our study. Our data suggest that the investigated parameters of serum HDL function showed no significant association with exudative AMD. However, we cannot exclude that alterations in locally produced HDL may be part of the AMD pathogenesis.
引用
下载
收藏
页数:14
相关论文
共 50 条
  • [21] Vitreomacular traction and exudative age-related macular degeneration
    Schulze, Stephan
    Hoerle, Steffen
    Mennel, Stefan
    Kroll, Peter
    ACTA OPHTHALMOLOGICA, 2008, 86 (05) : 470 - 481
  • [22] Radiating hemorrhage in exudative age-related macular degeneration
    Jae Hui Kim
    Young Suk Chang
    Jong Woo Kim
    Tae Gon Lee
    Chul Gu Kim
    Dong Won Lee
    Japanese Journal of Ophthalmology, 2016, 60 : 466 - 475
  • [23] Radiating hemorrhage in exudative age-related macular degeneration
    Kim, Jae Hui
    Chang, Young Suk
    Kim, Jong Woo
    Lee, Tae Gon
    Kim, Chul Gu
    Lee, Dong Won
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2016, 60 (06) : 466 - 475
  • [24] Transpupillary thermotherapy in exudative, age-related macular degeneration
    Haas, A
    Feigl, B
    Weger, M
    OPHTHALMOLOGE, 2003, 100 (02): : 111 - 114
  • [25] Fundus autofluorescence in exudative age-related macular degeneration
    Peng, Q.
    Dong, Y.
    Zhao, P. Q.
    GENETICS AND MOLECULAR RESEARCH, 2013, 12 (04) : 6140 - 6148
  • [26] Bimonthly Ranibizumab for Exudative Age-related Macular Degeneration
    Cohen, Salomon
    Maloberti, Bertrand
    Fajnkuchen, Franck
    Nghiem-Buffet, Sylvia
    Delahaye-Mazza, Corinne
    Grenet, Typhaine
    Quentel, Gabriel
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [27] Radiation therapy for exudative age-related macular degeneration
    Ciulla, TA
    Danis, RP
    Chakravarthy, U
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 1998, 18 (04): : 387 - 388
  • [28] Effect of unilateral exudative age-related macular degeneration on binocular visual function
    Quillen, DA
    ARCHIVES OF OPHTHALMOLOGY, 2001, 119 (11) : 1725 - 1726
  • [29] Use of a macular buckle in the treatment of exudative age-related macular degeneration
    Peyman, GA
    Conway, MD
    Recasens, MA
    Peralta, E
    Kertes, PJ
    Greve, MDJ
    El-Dessouky, ES
    OPHTHALMIC SURGERY AND LASERS, 1999, 30 (08): : 619 - 630
  • [30] Macular translocation with 360° retinotomy for exudative age-related macular degeneration
    Aisenbrey, S
    Lafaut, BA
    Szurman, P
    Grisanti, S
    Lüke, C
    Krott, R
    Thumann, G
    Fricke, J
    Neugebauer, A
    Hilgers, RD
    Esser, P
    Walter, P
    Bartz-Schmidt, KU
    ARCHIVES OF OPHTHALMOLOGY, 2002, 120 (04) : 451 - 459